Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 5/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9561776 | 0.76 | KMT2A (0.61) | KMT2AMEN1SMN1; SMN2LMNAHTT | |
| SCHEMBL5010826 | 0.75 | SMN1; SMN2 (0.54) | KMT2AMEN1SMN1; SMN2LMNAHTT | |
| SCHEMBL25547142 | 0.72 | CA12 (0.83) | KMT2AMEN1TP53SMN1; SMN2LMNA | |
| SCHEMBL29530578 | 0.72 | PRMT1 (0.74) | KMT2AMEN1POLBSMN1; SMN2LMNA | |
| SCHEMBL9305676 | 0.72 | PRMT1 (0.74) | KMT2AMEN1POLBSMN1; SMN2LMNA | |
| SCHEMBL5009915 | 0.71 | LMNA (0.52) | KMT2AMEN1SMN1; SMN2LMNAHTT | |
| SCHEMBL25254452 | 0.71 | KMT2A (0.62) | KMT2AMEN1SMN1; SMN2LMNAHTT | |
| SCHEMBL25267360 | 0.71 | LMNA (0.60) | KMT2AMEN1SMN1; SMN2LMNAHTT | |
| SCHEMBL21875079 | 0.70 | KLKB1 (0.48) | KMT2AMEN1TP53POLBALDH1A1 | |
| SCHEMBL13297941 | 0.70 | KMT2A (0.91) | KMT2AMEN1POLBSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250093329-A1 | SCREENING OF COMPOUNDS | THE UNIVERSITY OF TULSA | 2025-03-20 | — | — | US | disclosed |
| EP-4469592-A1 | SCREENING OF COMPOUNDS | The University Of Tulsa (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20230266302-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | THE UNIV OF TULSA (US) | 2023-08-24 | — | — | US | disclosed |
| WO-2023146904-A1 | SCREENING OF COMPOUNDS | THE UNIVERSITY OF TULSA (US) | 2023-08-03 | — | — | WO | disclosed |
| EP-4185706-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | The University Of Tulsa (US) | 2023-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230266302-A1 | SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES | ATP5ME, ATP5F1B, ATP5MG | KMT2A 1813/4885MEN1 3299/4885TP53 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.